Date published: 2026-5-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

Akt Inhibitor XII, Isozyme-Selective, Akti-2

0.0(0)
Write a reviewAsk a question

Application:
Akt Inhibitor XII, Isozyme-Selective, Akti-2 is a cell-permeable Akt1/2 inhibitor with improved solubility and Ak2 selectivity
Purity:
≥97%
Molecular Weight:
747.17
Molecular Formula:
C39H39N7O23HCl
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

A cell-permeable Akti-1/2- (Cat. No. 124018) derived allosteric inhibitor pair (1:1 regioisomeric mixture) with much improved aqueous solubility (10 mg/ml in a pH 7.4 saline) and Akt2 selectivity (IC50 = 805 nM for Akt2, >10 µM for Akt1/3, and >50 µM for PKA/PKC/SGK). The inhibition is PH domain-dependent and non-competitive with ATP.


Akt Inhibitor XII, Isozyme-Selective, Akti-2 References

  1. Development of potent, allosteric dual Akt1 and Akt2 inhibitors with improved physical properties and cell activity.  |  Zhao, Z., et al. 2008. Bioorg Med Chem Lett. 18: 49-53. PMID: 18054229
  2. Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cells.  |  Bokobza, SM., et al. 2014. Oncotarget. 5: 4765-78. PMID: 24946858
  3. Hyperphosphorylation of ribosomal protein S6 predicts unfavorable clinical survival in non-small cell lung cancer.  |  Chen, B., et al. 2015. J Exp Clin Cancer Res. 34: 126. PMID: 26490682

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Akt Inhibitor XII, Isozyme-Selective, Akti-2, 2 mg

sc-221230
2 mg
$480.00